<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140421017372N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-01</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of endotracheal intubation through the mouth and nose on the ease of intubation and cardiovascular status during intubation of patients with acute burns with severe airway obstruction.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of oro-tracheal  (classical) and naso-tracheal (blindly) intubation methods on ease of airway management and hemodynamic stability during intubation of acute burn patients with difficult airway condition</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59307</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block type is used for limited randomization. In this way, patients are divided into two groups by block randomization.
Assignment Sequences Using Web Systems
 Produced by www-sealedenvelope.com/.
In order to create an allocation sequence in this system, the number of subjects in each block was determined as 2 people.
Thus, the letter o was created for the group that is intubated orally and the N group was created for the group that is intubated nasally, and finally, by confirming the allocation sequence in the above system, 10 allocation sequences were created for 20 samples by combining the letters N and O.
Then the cards containing the blocks are placed inside the opaque envelope, thus concealing the allocation is also considered and observed, Blinding description: In this study, patients are unaware of the method to be used in intubation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Acute head and neck burns.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in group N are initially pre-oxygenated for 5 minutes and after administering a total of 6 puffs of 10% topical lidocaine in the nasopharynx, uro and hypopharynx, pass the endotracheal tube through the nostrils and intubate the patient with the help of breathing sound. We do. Intervention 2: Control group: Patients in group O are intubated according to the usual method after administration of midazolam (0.03 mg / kg), fentanyl (2 /g / kg), ketamine (1.5 kg / min) and laryngoscopy.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data, such as information about the main outcome, can be shared.

When:
Access period starts 3 months after the results are published

To whom:
The data will be available only to researchers working in academic and scientific institutions.

Conditions:
The data of this study can only be used in the field of research.

Where to obtain:
Refer to Dr. Reza Salehi.

How to obtain:
After sending the request and approval by Dr. Salehi et al., The data will be sent.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shayan Sanati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hazrate Rasoole Akram Hospital, Niayesh St, Satarkhan Av, Tehran, IRAN</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1445613131</zip>
        <telephone>+98 21 8880 4527</telephone>
        <email>shayansanati@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reza Salehi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Burn Motehari Hospital, Yasemi St., Vali-Asr St.,Vanak Sq.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۴۹۶۱۴۵۳۵</zip>
        <telephone>+98 21 8877 0031</telephone>
        <email>salehi.r@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with acute burns of the head and face
Patients with progressive airway obstruction or severe hypoxia are candidates for emergency intubation
difficult airway (Mallampati Ⅲ and Ⅳ)
Patients should have spontaneous breathing</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>57 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patient without spontaneous breathing
Patient with a history of underlying heart disease (severe liver disease, severe hemodynamic disorder and coagulation disorder)
Hypertension
Taking anticoagulants
Trauma to the head, face and neck
nose surgery  and nose anomaly
severe restlessness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in group N are initially pre-oxygenated for 5 minutes and after administering a total of 6 puffs of 10% topical lidocaine in the nasopharynx, uro and hypopharynx, pass the endotracheal tube through the nostrils and intubate the patient with the help of breathing sound. We do.</i_keyword>
      <i_keyword>Control group: Patients in group O are intubated according to the usual method after administration of midazolam (0.03 mg / kg), fentanyl (2 /g / kg), ketamine (1.5 kg / min) and laryngoscopy.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Number of endotracheal tubes consumed. Timepoint: First entry - during intubation - 5 minutes after intubation. Method of measurement: Counting by the nurse.</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: First entry - during intubation - 5 minutes after intubation. Method of measurement: Mercury barometer.</prim_outcome>
      <prim_outcome>Respiratory Rate. Timepoint: First entry - during intubation - 5 minutes after intubation. Method of measurement: Pulse oximetry.</prim_outcome>
      <prim_outcome>Arterial oxygen saturation level. Timepoint: First entry - during intubation - 5 minutes after intubation. Method of measurement: Pulse oximetry.</prim_outcome>
      <prim_outcome>Heart rate. Timepoint: First entry - during intubation - 5 minutes after intubation. Method of measurement: Chest lead connected to the monitor.</prim_outcome>
      <prim_outcome>Number of intubation attempts. Timepoint: First entry - during intubation - 5 minutes after intubation. Method of measurement: Counting with the help of a nurse.</prim_outcome>
      <prim_outcome>Apnea and cardiac arrest. Timepoint: First entry - during intubation - 5 minutes after intubation. Method of measurement: by nurse.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-01-03</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Tehran, Hemmat Highway next to Milad Tower Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
